← Back to Search

MI for Hepatitis C (REACH Trial)

N/A
Waitlist Available
Led By Michael Stein, MD
Research Sponsored by Butler Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 24 months
Awards & highlights

REACH Trial Summary

This trial will compare the effects of two types of brief intervention - Brief Advice (BA) and Motivational Interviewing (MI) - on reducing drinking in HIV-positive patients.

Eligible Conditions
  • Hepatitis C
  • HIV/AIDS

REACH Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 24 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 24 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Alcohol Use questionnaire

REACH Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: MIActive Control1 Intervention
Participants in this arm will receive a talking intervention designed to explore their interest in reducing/eliminating alcohol use. Sessions will occur at the baseline interview and every three months for 18 months.
Group II: Brief AdvicePlacebo Group1 Intervention
Participants in this arm will receive brief advice about alcohol use. Sessions will occur at the baseline interview and every three months for 18 months.

Find a Location

Who is running the clinical trial?

Butler HospitalLead Sponsor
129 Previous Clinical Trials
16,118 Total Patients Enrolled
1 Trials studying Hepatitis C
277 Patients Enrolled for Hepatitis C
Michael Stein, MDPrincipal InvestigatorButler Hospital
9 Previous Clinical Trials
1,833 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
AIDS and BehaviorJournal
A Randomized Trial Comparing Brief Advice and Motivational Interviewing for Persons with HIV–HCV Co-infection Who Drink Alcohol
Stein, Michael D., Debra S. Herman, H. Nina Kim, Abigail Howell, Audrey Lambert, Stephanie Madden, Ethan Moitra, et al.. 2020. “A Randomized Trial Comparing Brief Advice and Motivational Interviewing for Persons with HIV–HCV Co-infection Who Drink Alcohol”. AIDS and Behavior. Springer Science and Business Media LLC. doi:10.1007/s10461-020-03062-2.
clinicaltrials.govStudy
Comparing Brief Alcohol Interventions For HIV-HCV Co-infected Persons
Michael Stein, MD 2015. "Comparing Brief Alcohol Interventions For HIV-HCV Co-infected Persons". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02316184.
~29 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top